European Journal of Inflammation (Sep 2003)

Losartan Increases No Production from the Bovine Aortic Wall That is Stimulated by Angiotensin II

  • M. Myronidou,
  • B. Kokkas,
  • A. Kouyoumtzis,
  • N. Gregoriadis,
  • A. Lourbopoulos,
  • I. Mylonas,
  • P.C. Papadopoulos,
  • C.L. Papadopoulos,
  • V. Mirtsou–Fidani

DOI
https://doi.org/10.1177/1721727X0300100304
Journal volume & issue
Vol. 1

Abstract

Read online

In these studies we investigated if losartan, an AT 1 - receptor blocker has any beneficial effect on NO production from the bovine aortic preparations in vitro while under stimulation from angiotensin II. Experiments were performed on intact specimens of bovine thoracic aorta, incubated in Dulbeco's MOD medium in a metabolic shaker for 24 hours under 95 % O 2 and 5 % CO 2 at a temperature of 37°C. We found that angiotensin II 1nM −10 μM does not exert any statistically significant action on NO production. On the contrary, angiotensin II 10nM increases the production of NO by 58.14 % (from 12.16 + 2.9 μm/l to 19.23 + 4.2 μm/l in the presence of losartan 1nM (P<0.05). Nitric oxide levels depend on both rate production and rate catabolism or chemical inactivation. Such an equilibrium is vital for the normal function of many systems including the cardiovascular one. The above results demonstrate that the blockade of AT 1 -receptors favors the biosynthesis of NO and indicate the protective role of losartan on the vascular wall.